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Abstract
Reactivation of herpes simplex virus type 1 (HSV-1) in
the vestibular ganglion (VG) is the suspected cause of
vestibular neuritis (VN). Recent studies reported the
presence of HSV-1 DNA not only in human VGs but also
in vestibular nuclei, a finding that indicates the possibili-
ty of viral migration to the human vestibular labyrinth.
Distribution of HSV-1 DNA was determined in geniculate
ganglia, VGs, semicircular canals, and macula organs of
21 randomly obtained human temporal bones by nested
PCR. Viral DNA was detected in 48% of the labyrinths,
62% of the VGs, and 57% of the geniculate ganglia. The
potential significance of this finding is twofold: (1) In-
flammation in VN could also involve the labyrinth and
thereby cause acute unilateral vestibular deafferenta-
tion. (2) As benign paroxysmal positional vertigo often
occurs in patients who have had VN, it could also be a
sequel of viral labyrinthitis.
Copyright © 2001 S. Karger AG, Basel
Introduction
The reactivation of latent herpes simplex virus type 1
(HSV-1) in human geniculate ganglia (GGs) and vestibu-
lar ganglia (VGs) is the assumed etiology of Bell’s palsy
and vestibular neuritis (VN) [Schuknecht and Kitamura,
1981; Furuta et al., 1993; Adour et al., 1996; Murakami et
al., 1996]. It is widely accepted that after primary infec-
tion (stomatitis herpetica) HSV-1 ascends to associated
sensory ganglia by retrograde axonal transport, e.g., via
chorda tympani in the GG and via faciovestibular anasto-
mosis to the VG [Bergström, 1973; Whitley, 1988]. A
recent study reported the presence of HSV-1 not only in
VGs but also in vestibular nuclei, thus indicating that
viral migration can also occur via the vestibular nerve to
the pontomedullary brainstem [Arbusow et al., 2000]
(fig. 1). This finding raises the question of whether the
virus could also migrate from the VGs to the peripheral
receptors in the semicircular canals (SCCs) and the oto-
lithic organs. Viral inflammation could also involve the
peripheral labyrinth and thereby cause acute unilateral
vestibular dysfunction typical of VN. To determine the
distribution of HSV-1 DNA in VGs, GGs, SCCs, and
macula organs (utricle and saccule), 21 randomly ob-
tained temporal bones of 11 individuals were examined
for HSV-1-specific DNA by nested polymerase chain
reaction (PCR).
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Fig. 1. After primary infection (stomatitis herpetica) HSV-1 ascends to the geniculate ganglion (GG) via chorda
tympani and via the faciovestibular anastomosis to the vestibular ganglion (VG). Viral migration to the vestibular
nuclei (VNc) and the human labyrinth is possible along the vestibular nerve. aSCC, hSCC, pSCC = Anterior, horizon-
tal, and posterior semicircular canals; cc = commissural connections.
Table 1. Distribution of HSV-1-specific DNA in human VGs, GGs,
and vestibular labyrinth (VL; semicircular canals, utricle, and sac-
cule)
Temporal
bone No.
Age Sex GG VG VL
42 years f + – –
2 4 months f – – –
3 4 months f – – –
4 53 years f + + –
5 53 years f + + –
6 37 years m – + +
7 37 years m – + +
8 27 years m – – –
9 27 years m + – –
10 58 years f – – –
11 58 years f + – –
12 43 years m + + +
13 43 years m + – –
14 35 years m + + +
15 35 years m + + +
16 35 years f – + +
17 35 years f – + +
18 35 years m – + –
19 35 years m + + +
20 50 years m + + +
21 50 years m + + +
Positives 12/21 13/21 10/21
Materials and Methods
The Ethics Committee of the Medical Faculty of the Ludwig
Maximilians University of Munich approved the study. Twenty-one
temporal bones of 11 individuals, obtained from the Institute of
Forensic Medicine of the University of Munich, were dissected dur-
ing autopsy and immediately stored at –20°C. In all cases the cause
of death was neither natural nor related to cranial nerve dysfunction.
None of the individuals had had a history of central or peripheral
vestibular vertigo, VN, benign paroxysmal positional vertigo, or
Ménière’s disease. Viral infections (human immunodeficiency virus;
hepatitis C virus, hepatitis B virus, herpes simplex encephalitis) and
immunosuppression were also excluded. As 80–90% of healthy
adults have antibodies against HSV-1, the sera of the individuals
were not checked for HSV-1-specific antibodies. Age distribution
ranged from 4 months to 58 years (6 males and 5 females). The bony
surface (from the entrance of the intrameatal duct to the GG on the
opposite side of the temporal bone) was removed with a binocular
and an electric drill until the dura that surrounds the vestibuloco-
chlear and facial nerves was exposed. After the dural sac was opened,
the VG and the facial and cochlear nerves were also removed. Then,
the stapes was separated from the fenestra vestibuli, which was care-
fully opened and widened with a microdrill. Next the temporal
bones were split into two halves along the internal auditory canal
through the middle of the vestibulum with surgical scissors: one half
contained the cochlear and the other the labyrinthine structures.
Finally, a microforceps was used to carefully remove the SCCs,
utricle, and saccule of each labyrinth from the bony structures
(fig. 2a, b) and to pool them for DNA extraction (QUIAamp® DNA
mini kit; Qiagen).
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Fig. 2. a Human posterior SCC (short arrow) drawn out of its bony canal (open arrow); vestibulum (long arrow).
b Macula utriculi (long arrow) in the human vestibulum (bold arrow); ductus utricularis (small arrow).
Fig. 3. HSV-1-specific PCR products (137
bp) from 10 human labyrinths. Lane M =
Molecular weight marker; lane 1 = positive
control; lane 12 = human blood DNA (nega-
tive control); lane 13 = water control; lanes 2
and 3 = labyrinths No. 2 and 3; lanes 4–7 =
labyrinths No. 14–17; lanes 8–11 = laby-
rinths No. 14–17; lanes 8–11 = labyrinths
No. 4–7.
Nested PCR for HSV-1 glycoprotein D gene was carried out
according to the method described by Aurelius et al. [1991]. The
sequences of the primers and their location in the glycoprotein D
gene of HSV-1 were as follows: (1) outer 5)-primer (position 19–43):
ATCACGGTAGCCCGGCCGTGTGACA; (2) outer 3)-primer
(218–239): CATACCGGAACGCACCACACAA; (3) inner 5)-primer
(51–71): CCATACCGACCACACCGACGA, and (4) inner 3)-prim-
er (166–188): GGTAGTTGGTCGTTCGCGCTGAA.
All reagents and the equipment for PCR were purchased from
Biometra, Göttingen, Germany. All DNA samples were amplified 25
times with the outer and then 25 times with the inner primers. The
temperature profile was 30 s at 95°C, 30 s at 60°C, and 1 min at
72°C. PCR products were analyzed on 3% agarose gels (fig. 3). To
confirm the presence of amplifiable DNA in the nucleic acid prepara-
tions, a nonpolymorphic mitochondrial fragment of 530 base pairs
was demonstrated in a parallel PCR [Schulz et al., 1998]. Human
blood DNA from a healthy individual and a water control were
included as negative controls for each PCR run. To exclude false pos-
itives, all positive reactions were repeated at least once.
Results
HSV-1 DNA was detected in 10 of the 21 vestibular
labyrinths (48%). Four individuals showed bilateral HSV-
1 infection of the labyrinth. HSV-1 infection of the laby-
rinth was always associated with the detection of HSV-1
DNA in the ipsilateral VG. In only 3 of 13 cases was HSV-
1 DNA found in the VG but not in the ipsilateral vestibu-
lar labyrinth (table 1). Frequency and distribution of
HSV-1 DNA among the VGs (13/21; 62%) and GGs (12/
21; 57%) did not differ substantially from findings in ear-
lier studies [Furuta et al., 1993; Schulz et al., 1998; Arbu-
sow et al., 1999]. In 5 cases, HSV-1 infection of the VG
was not associated with infection of the GG. As in other
recent studies [Schulz et al., 1998; Arbusow et al., 1999,
2000], bilateral infection was a common finding; it was
detected in the VGs of 6 and in the GGs of 4 individuals.
As viral infections (human immunodeficiency virus; hep-
atitis C virus, hepatitis B virus, herpes simplex encephali-
tis) and immunosuppression were excluded in these indi-
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viduals, bilateral involvement of the cranial nerve ganglia
did not indicate a severe underlying disease.
Discussion
Several lines of evidence support a viral hypothesis of
VN, for example temporal bone pathology in patients
with VN [Schuknecht and Kitamura, 1981], its epidemic
occurrence in certain periods of the year [Silvoniemi,
1988; Sekitani et al., 1993], and the common detection of
HSV-1 DNA in human VGs and central vestibular nuclei
[Furuta et al., 1993; Arbusow et al., 1999, 2000]. This is
the first demonstration of HSV-1 DNA in the human
SCCs and otolithic organs. It suggests that oculomotor
signs in acute VN (horizontal rotatory spontaneous nys-
tagmus to the nonaffected ear) may not be exclusively
caused by viral inflammation of the superior vestibular
nerve [Strupp and Arbusow, 2001] but also be a sequel of
viral inflammation of the peripheral vestibular labyrinth.
Benign paroxysmal positional vertigo occurs relatively
often in patients who have had VN (about 12%) [Büchele
and Brandt, 1988]; it may also be induced by viral laby-
rinthitis. Inflammation of the labyrinth could lead to a
loosening of otoconia, which enter the SCCs causing cana-
lolithiasis and subsequently benign paroxysmal positional
vertigo.
As there was no single case in which HSV-1 DNA was
detected in the human labyrinth but not in the associated
VG (table 1), a centrifugal viral migration from the VG to
the peripheral vestibular labyrinth seems more likely than
primary viral infection of the labyrinths (e.g., via fenestra
vestibuli in the middle ear). Also the finding of 5 cases
showing HSV-1 infection of the VG without involvement
of the ipsilateral GG (table 1) does not necessarily exclude
viral spreading from the GG to the VGs via faciovestibu-
lar anastomosis. The absence of viral DNA in the GG
could be due to reactivation and subsequent clearance of
the virus, as a result of virus- or immune-mediated
destruction of the previously infected neurons [Whitley,
1988]. However, it is also possible that HSV-1 may first
infect the VG, e.g., via infected T lymphocytes or via the
vestibular labyrinth, and then secondarily migrate to the
GG [Arbusow et al., 2000].
In conclusion, this study showed that HSV-1 DNA is a
common finding not only in human VGs but also in the
labyrinth. The pattern of viral distribution in this study
does not allow us to determine a specific route of viral
spreading. Several mechanisms are possible to explain the
pattern of viral distribution: (1) viral migration along
anastomoses, (2) hematogenic infection by HSV-1-in-
fected T lymphocytes, and (3) direct infection of the ves-
tibular labyrinth (e.g., via fenestra vestibuli in the middle
ear). The next logical step is to determine the exact cellu-
lar location of HSV-1 in the human vestibular system by
using in situ PCR methods that amplify viral DNA and
RNA.
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